Orange Apricot
A citrus-forward hybrid with a sparse documented record, sold mostly on terpene profile rather than verified pedigree.
Orange Apricot is one of those strains that exists more in dispensary menus than in any verifiable record. The lineage attributed to it online is inconsistent, no peer-reviewed work has profiled it specifically, and 'cannabis strain' as a category is genetically unreliable to begin with. What you can reasonably expect is a citrus-and-stone-fruit terpene nose driven by limonene and likely some myrcene or caryophyllene. Effects vary by chemotype, dose, and individual — not by the name on the jar. Buy by lab data, not branding.
Overview
Orange Apricot is a citrus-and-stone-fruit-scented cannabis variety that circulates on North American dispensary menus and seed-vendor sites. Unlike well-documented cultivars such as Chemdog or OG Kush, Orange Apricot lacks a clear breeder of record, a published pedigree, or any peer-reviewed chemotyping. No data
Most of what is written about it comes from retailer copy and crowdsourced strain databases, which are known to recycle each other's claims without verification [1]. Treat the name as a marketing label for a fruity-smelling hybrid rather than a stable genetic line.
Chemistry
There is no published cannabinoid or terpene assay of Orange Apricot in the peer-reviewed literature. No data Vendor-reported THC values cluster in the high-teens to low-20s percent range, with negligible CBD — which is typical of nearly all modern THC-dominant hybrids and tells you little specific about this cultivar [2].
The name implies a limonene-forward terpene profile, often paired with myrcene and/or beta-caryophyllene, which together can produce citrus-peel and apricot-skin aromas [3]. However, terpene content within a single named strain varies widely across grows and phenotypes; a 2022 analysis of commercial cannabis found that strain name is a poor predictor of chemotype [4]. If limonene character matters to you, buy a batch with a current certificate of analysis showing it — don't trust the name.
Reported effects
No clinical trials have studied Orange Apricot specifically, and none are likely to. No data Anecdotal reports describe an upbeat, talkative head effect with mild body relaxation Anecdote — essentially the modal description for any THC-dominant hybrid online.
The popular framing that limonene is inherently 'uplifting' or that myrcene above 0.5% causes a 'couch-lock' indica effect is folklore, not pharmacology. The myrcene threshold in particular has been repeatedly debunked as having no identifiable scientific origin [5]. Disputed Effects from any cannabis product are driven primarily by THC dose, route of administration, individual tolerance, and setting — not by the strain name [6].
Lineage
Lineage claims for Orange Apricot are inconsistent across sources. Some retailers describe it as a cross involving Orangeade or Orange Push Pop with an apricot-leaning parent; others list it simply as a 'fruity hybrid' with no parents specified. No breeder has publicly documented the cross with verifiable provenance. No data
This is not unusual. Cannabis 'strain' nomenclature is notoriously unreliable: a 2018 genetic study found that samples sold under the same strain name were frequently not genetically related, and samples with different names were sometimes nearly identical [7]. Until a breeder publishes seeds with a documented pedigree, assume Orange Apricot from one dispensary is not the same plant as Orange Apricot from another.
Cultivation basics
Because there is no canonical Orange Apricot line, cultivation parameters are not meaningfully documented. Vendors report an 8–9 week flowering window indoors, which is unremarkable for a photoperiod hybrid Weak / limited. Yield, height, stretch, and disease resistance are not described in any reliable practitioner record we could verify. No data
General guidance for any citrus-terpene hybrid applies: terpenes are volatile and degrade with heat, light, and rough handling, so cure slowly at moderate humidity (around 58–62% RH) and store cold and dark to preserve the limonene character that is presumably the whole point of growing this variety [8].
Marketing vs. reality
Marketing claim: Orange Apricot is a balanced hybrid with uplifting, mood-boosting effects from its limonene-rich profile.
Reality: No published data confirm its terpene profile, lineage, or effects. Limonene being 'uplifting' is a popular but weakly evidenced claim — small human trials exist for limonene's anxiolytic effects at high doses, but they don't translate cleanly to inhaled cannabis at trace concentrations [9]. Weak / limited
Marketing claim: It's good for anxiety, depression, and stress.
Reality: These are not strain-specific medical claims that any evidence supports. Cannabis can acutely reduce anxiety at low THC doses and worsen it at high doses in the same person; this dose-response pattern is well documented and has nothing to do with strain name [10].
If Orange Apricot smells great to you and the lab report shows the cannabinoid and terpene levels you want, enjoy it. Just don't pay a premium for the name.
Sources
- Peer-reviewed McPartland, J. M., & Small, E. (2020). A classification of endangered high-THC cannabis (Cannabis sativa subsp. indica) domesticates and their wild relatives. PhytoKeys, 144, 81–112.
- Peer-reviewed ElSohly, M. A., Chandra, S., Radwan, M., Majumdar, C. G., & Church, J. C. (2021). A comprehensive review of cannabis potency in the United States in the last decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6(6), 603–606.
- Peer-reviewed Hazekamp, A., Tejkalová, K., & Papadimitriou, S. (2016). Cannabis: From cultivar to chemovar II—A metabolomics approach to cannabis classification. Cannabis and Cannabinoid Research, 1(1), 202–215.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Reported Jikomes, N. (2021). The 'myrcene rule' and other cannabis terpene myths. Leafly.
- Peer-reviewed Russo, E. B. (2019). The case for the entourage effect and conventional breeding of clinical cannabis: No 'strain,' no gain. Frontiers in Plant Science, 9, 1969.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1, 3.
- Peer-reviewed Ross, S. A., & ElSohly, M. A. (1996). The volatile oil composition of fresh and air-dried buds of Cannabis sativa. Journal of Natural Products, 59(1), 49–51.
- Peer-reviewed Lima, N. G., De Sousa, D. P., Pimenta, F. C., et al. (2013). Anxiolytic-like activity and GC-MS analysis of (R)-(+)-limonene fragrance. Pharmacology Biochemistry and Behavior, 103(3), 450–454.
- Peer-reviewed Childs, E., Lutz, J. A., & de Wit, H. (2017). Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug and Alcohol Dependence, 177, 136–144.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.